Epidemiology of recurrent venous thrombosis

Venous thrombosis, including deep vein thrombosis and pulmonary embolism, is a common disease that frequently recurs. Recurrence can be prevented by anticoagulants, but this comes at the risk of bleeding. Therefore, assessment of the risk of recurrence is important to balance the risks and benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Ribeiro, D.D., Lijfering, W.M., Barreto, S.M., Rosendaal, F.R., Rezende, S.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Medicina Tropical 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854137/
https://www.ncbi.nlm.nih.gov/pubmed/22183247
http://dx.doi.org/10.1590/S0100-879X2011007500166
_version_ 1782294739393970176
author Ribeiro, D.D.
Lijfering, W.M.
Barreto, S.M.
Rosendaal, F.R.
Rezende, S.M.
author_facet Ribeiro, D.D.
Lijfering, W.M.
Barreto, S.M.
Rosendaal, F.R.
Rezende, S.M.
author_sort Ribeiro, D.D.
collection PubMed
description Venous thrombosis, including deep vein thrombosis and pulmonary embolism, is a common disease that frequently recurs. Recurrence can be prevented by anticoagulants, but this comes at the risk of bleeding. Therefore, assessment of the risk of recurrence is important to balance the risks and benefits of anticoagulant treatment. This review briefly outlines what is currently known about the epidemiology of recurrent venous thrombosis, and focuses in more detail on potential new risk factors for venous recurrence. The general implications of these findings in patient management are discussed.
format Online
Article
Text
id pubmed-3854137
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Sociedade Brasileira de Medicina Tropical
record_format MEDLINE/PubMed
spelling pubmed-38541372013-12-16 Epidemiology of recurrent venous thrombosis Ribeiro, D.D. Lijfering, W.M. Barreto, S.M. Rosendaal, F.R. Rezende, S.M. Braz J Med Biol Res Review Venous thrombosis, including deep vein thrombosis and pulmonary embolism, is a common disease that frequently recurs. Recurrence can be prevented by anticoagulants, but this comes at the risk of bleeding. Therefore, assessment of the risk of recurrence is important to balance the risks and benefits of anticoagulant treatment. This review briefly outlines what is currently known about the epidemiology of recurrent venous thrombosis, and focuses in more detail on potential new risk factors for venous recurrence. The general implications of these findings in patient management are discussed. Sociedade Brasileira de Medicina Tropical 2011-12-23 /pmc/articles/PMC3854137/ /pubmed/22183247 http://dx.doi.org/10.1590/S0100-879X2011007500166 Text en http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Ribeiro, D.D.
Lijfering, W.M.
Barreto, S.M.
Rosendaal, F.R.
Rezende, S.M.
Epidemiology of recurrent venous thrombosis
title Epidemiology of recurrent venous thrombosis
title_full Epidemiology of recurrent venous thrombosis
title_fullStr Epidemiology of recurrent venous thrombosis
title_full_unstemmed Epidemiology of recurrent venous thrombosis
title_short Epidemiology of recurrent venous thrombosis
title_sort epidemiology of recurrent venous thrombosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854137/
https://www.ncbi.nlm.nih.gov/pubmed/22183247
http://dx.doi.org/10.1590/S0100-879X2011007500166
work_keys_str_mv AT ribeirodd epidemiologyofrecurrentvenousthrombosis
AT lijferingwm epidemiologyofrecurrentvenousthrombosis
AT barretosm epidemiologyofrecurrentvenousthrombosis
AT rosendaalfr epidemiologyofrecurrentvenousthrombosis
AT rezendesm epidemiologyofrecurrentvenousthrombosis

Ejemplares similares